Floatz logo

Therapeutic Asset Ratings

4,361 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Obinutuzumab
Mantle Cell Lymphoma
National Cancer Institute (NCI)P2BB (64)
Olaparib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2BB (64)
Olaparib
Central Nervous System Neoplasm
National Cancer Institute (NCI)P2BB (64)
Olaparib
Refractory Primary Central Nervous System Neoplasm
National Cancer Institute (NCI)P2BB (64)
Palbociclib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2BB (64)
Sotorasib
Lung Cancer
National Cancer Institute (NCI)P2BB (64)
Talzenna
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P2BB (64)
Veliparib
Pancreatic Adenocarcinoma
National Cancer Institute (NCI)P2BB (64)
Veliparib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2BB (64)
vx-970
Small Cell Carcinoma
National Cancer Institute (NCI)P2BB (64)
Hycamtin
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)P2/3BB (64)
Hycamtin
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)P2/3BB (64)
Hycamtin
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2/3BB (64)
Inno-206
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2/3BB (64)
Nivolumab
Urinary Bladder Carcinoma
National Cancer Institute (NCI)P2/3BB (64)
PREDNISONE TABLETS
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2/3BB (64)
Relatlimab
Urethra Transitional Cell Carcinoma
National Cancer Institute (NCI)P2/3BB (64)
Relatlimab
Muscle Invasive Ureter Urothelial Carcinoma
National Cancer Institute (NCI)P2/3BB (64)
URSODEOXYCHOLIC ACID
Familial Adenomatous Polyposis
National Cancer Institute (NCI)P2/3BB (64)
Venetoclax
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)P2/3BB (64)
VINCRISTINE SULFATE
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2/3BB (64)
VINCRISTINE SULFATE
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
National Cancer Institute (NCI)P2/3BB (64)
Palifermin
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P4B (63)
TACROLIMUS
Lymphoma
National Cancer Institute (NCI)P4B (63)
Abemaciclib
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P3B (63)
Showing 476 to 500 of 4,361 assets
PreviousPage 20 of 175Next